arginyl-glycyl-aspartic acid has been researched along with Barrett Esophagus in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bergman, JJ; Bosma, PJ; Buskens, CJ; Marsman, WA; Offerhaus, GJ; Tytgat, GN; van Lanschot, JJ; Wesseling, JG | 1 |
1 other study(ies) available for arginyl-glycyl-aspartic acid and Barrett Esophagus
Article | Year |
---|---|
Gene therapy for esophageal carcinoma: the use of an explant model to test adenoviral vectors ex vivo.
Topics: Adenoviridae; Barrett Esophagus; Carcinoma; Cell Line, Tumor; Coxsackie and Adenovirus Receptor-Like Membrane Protein; Esophageal Neoplasms; Flow Cytometry; Genetic Therapy; Genetic Vectors; Humans; Immunochemistry; Oligopeptides; Receptors, Virus; Transduction, Genetic | 2004 |